Click to search for your profile
Click to search for condition or expert
Click to open main menu
Cytomegalic Inclusion Disease Clinical Trials
Find Cytomegalic Inclusion Disease clinical trials near you.
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Biological
Participants:
25
Start Date:
June 23, 2021
Viral Specific T-Lymphocytes by Cytokine Capture System (CCS) to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus After Hematopoietic Cell Transplantation or Solid Organ Transplantation and in Patients With Compromised Immunity
Clinical Trial
Status:
Not yet recruiting
Participants:
5000
Start Date:
May 1, 2021
Congenital Cytomegalovirus Infection in Vietnam: Prevalence, Morbidity and Risk Factors
Search for trials
Clinical Trial
Status:
Recruiting
Phase:
N/A
Intervention Type:
Drug
Participants:
10
Start Date:
April 2021
Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Randomized Against Valaciclovir - STEP 1
Clinical Trial
Status:
Active, not recruiting
Participants:
800
Start Date:
April 1, 2021
Deep Learning-based System for Detection of AIDS-related Cytomegalovirus Retinitis in Ultra-Widefield Fundus Images
Clinical Trial
Status:
Recruiting
Phase:
N/A
Intervention Type:
Behavioral
Participants:
840
Start Date:
January 11, 2021
Prenatal Behavioral Intervention to Prevent Maternal Cytomegalovirus (CMV) in Pregnancy
Clinical Trial
Status:
Recruiting
Intervention Type:
Other
Participants:
135
Start Date:
January 1, 2021
Assessment of Post-traumatic Stress Disorder (PTSD) in Patients Monitored for Cytomegalovirus (CMV) Seroconversion During Pregnancy, Without Ultrasound Signs or With Non-serious Ultrasound Signs of Maternal-fetal CMV Infection.
Clinical Trial
Status:
Recruiting
Participants:
40
Start Date:
November 2020
Breakthrough CMV DNAemia in CMV Seronegative Recipients of CMV Seropositive Lung Transplantation During Antiviral Prophylaxis With Valganciclovir. A Pilot Study.
Clinical Trial
Status:
Recruiting
Intervention Type:
Other
Participants:
400
Start Date:
September 24, 2020
Real-life Observatory of Efficacy and Resistance to Anti CMV Molecules in Stem Cell Recipients
Clinical Trial
Status:
Not yet recruiting
Intervention Type:
Drug
Participants:
100
Start Date:
September 15, 2020
Cytomegalovirus (CMV) Viremia and Disease Occurrence in Pediatric Allogeneic Stem Cell Transplantation Recipients Following Ganciclovir Prophylaxis Until Day +100
Clinical Trial
Status:
Recruiting
Phase:
Phase 4
Intervention Type:
Diagnostic Test
Participants:
188
Start Date:
June 12, 2020
Phase IV Clinical Trial, Open, Randomized, Controlled and Multicentric, With Two Parallel Groups, to Assess the Efficacy of a Preventive Strategy Against Cytomegalovirus Infection in Heart Transplant Patients, Based on the Specific Basal T Cell Response Against Cytomegalovirus: ELISPOT-TC
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
108
Start Date:
June 1, 2020
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of NPC-21 for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection
Clinical Trial
Status:
Not yet recruiting
Intervention Type:
Diagnostic Test
Participants:
400
Start Date:
March 1, 2020
Incidence, Natural History and Outcome of Cytomegalovirus Infection in Critically Ill Patients and Patients Receiving Anticancer Therapy
Showing 1-12 of 50
Next